The Polish Competition Authority clears a merger in the pharmaceuticals sector, subject to a divestment remedy (Sanofi-Synthelabo / Aventis)

The operation The acquisition of Aventis by Sanofi-Synthelabo was performed by a public bid. The President of the OCCP, on 18 May 2004, cleared the merger, which led to the establishment of one of the largest pharmaceutical groups in the world (pages 3-5). The market(s) The President of the OCCP assessed that the proposed concentration would horizontally affect the pharmaceutical

Access to this article is restricted to subscribers

Already Subscribed? Sign-in

Access to this article is restricted to subscribers.

Read one article for free

Sign-up to read this article for free and discover our services.

 

PDF Version

Author

Quotation

Marcin Bartnicki, The Polish Competition Authority clears a merger in the pharmaceuticals sector, subject to a divestment remedy (Sanofi-Synthelabo / Aventis), 18 May 2004, e-Competitions Bulletin May 2004, Art. N° 21046

Visites 2488

All issues

  • Latest News issue 
  • All News issues
  • Latest Special issue 
  • All Special issues